Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04473716 Completed - Oral Cancer Clinical Trials

Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients

Start date: July 30, 2020
Phase: Phase 1
Study type: Interventional

The aim of this study is to use the combination of immune checkpoint inhibitor of Toripalimab, and chemotherapy agents of TP, as a neoadjuvant therapy to treat the patients with locally advanced OSCC, followed with radical surgery and post-operative radiotherapy/chemoradiotherapy, the major pathological response and safety will be evaluated as the primary surrogate endpoints, the 2-year survival rate and local recurrence rate will be the second endpoints.

NCT ID: NCT04473664 Completed - Hepatic Impairment Clinical Trials

A Study of Quizartinib Pharmacokinetics in Participants With Moderate Hepatic Impairment

Start date: September 22, 2020
Phase: Phase 1
Study type: Interventional

Quizartinib is a novel oral Class III receptor tyrosine kinase (RTK) inhibitor exhibiting highly potent and selective but reversible inhibition of Feline McDonough sarcoma (FMS)-like tyrosine kinase 3 (FLT3). Quizartinib is currently being studied alone or in combination with other agents as a treatment for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in adult and pediatric populations.

NCT ID: NCT04473638 Completed - Ankle Fractures Clinical Trials

Deltoid Ligament Arthroscopic Repair in Ankle Fractures: Case Series

Start date: August 1, 2019
Phase:
Study type: Observational

To demonstrate the functional results of patients with ankle fractures operated with arthroscopic deltoid repair.

NCT ID: NCT04473287 Completed - Clinical trials for Coronary Artery Bypass Graft Surgery

The Effect of Reflexology After Coronary Artery Bypass Graft Surgery

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Coronary artery bypass graft (CABG) surgery is a treatment method that increases survival rate in the treatment of coronary artery disease (CAD). CABG surgery can create anxiety, fear, pain, fatigue, sleep disorders and physiological dysfunctions in patients. Nurses responsible for the care and treatment of patients use pharmacological and non-pharmacological methods to alleviate the problems that arise. In this context, reflexology within complementary and alternative therapy (CAM) can be applied. In this study, it is aimed to evaluate the effect of reflexology applied to patients undergoing coronary artery bypass graft surgery on pain, anxiety, fatigue, sleep and physiological parameters.

NCT ID: NCT04472533 Completed - Clinical trials for Pulmonary Hypertension, Primary, 4

Serum Bio-markers in Pulmonary Hypertension

Start date: April 4, 2012
Phase:
Study type: Observational

Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by scarred blood clots in the blood vessels supplying the lungs. This in turn leads to failure of the right side of the heart. The reason why these scarred clots form is unknown. An operation to remove the scarred clots, known as pulmonary endarterectomy, is a potential cure. However, some patients have persistent obstructions within the blood vessels and heart failure even after surgery. It is thought that abnormal levels of proteins, found in the blood stream and responsible for inflammation and the development of new blood vessels may have role in causing the disease. In this study, these proteins were measured to assess whether they provide clues as to the cause of the disease and whether they could be used for the risk stratification of patients.

NCT ID: NCT04471610 Completed - Clinical trials for Acute Decompensated Heart Failure

Point Of Care With Serial NT-proBNP Measurement in Patients With Acute Decompensation of Heart Failure

Start date: January 23, 2018
Phase: N/A
Study type: Interventional

The goal of this study is to explore whether the availability of serial NT-proBNP measurements together with safety parameters such as electrolytes and creatinine may influence treatment decision in patients with acute decompensated heart failure (ADHF) leading to more rapid and faster dose increase of prognostic therapies and earlier hospital discharge.

NCT ID: NCT04471285 Completed - Clinical trials for Pain/Sensitivity >5 on Numeric Rating Scale (NRS)

Symphysiolysis: Acupuncture Therapeutic Benefits: a Randomized Placebo Controlled Study.

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

a randomized, observer blind and placebo-controlled cross-over study in which true acupuncture (Verum)(V) was compared to "placebo" acupuncture (P). the investigators evaluate the effect of the acupuncture on the pain and the ability of the pregnant patient.

NCT ID: NCT04470960 Completed - Clinical trials for A Community Center as a Health Promoting Setting

Evaluation of a Health Promoting Community Center Network (HPCCN) Innovation.

HPCCN
Start date: December 11, 2017
Phase: N/A
Study type: Interventional

The purpose of this research study is to design, implement and evaluate the setting for a "Healthy Community Center". This is a program review of a program which will be planned in a community based participatory level, based on the socioecological model. A pre-post design will be utilized where all community centers in the study will be exposed to the intervention components. It is hypothesized that community centers who will receive the intervention will have better skills at building sustainable participatory effective health promotion projects and will provide a healthy setting for the community within its juristiction.

NCT ID: NCT04470765 Completed - Clinical trials for Urinary Incontinence

Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence

Start date: September 15, 2020
Phase: N/A
Study type: Interventional

Tibial nerve stimulation (TNS) has been shown to be an effective alternative for the management of the overactive bladder (OAB). Transcutaneous Tibial Nerve Stimulation (TTNS) uses a series of regular electrical pulses to stimulate the tibial nerve. Numerous studies have positively shown the efficacy of this treatment. These studies have included multicentric, double-blind, randomized sham-controlled study of patients with idiopathic OAB. , . In 2013 the British National Institute for Health and Care Excellence (NICE) guidance has added TTNS as a second-line option for the management of female urinary incontinence , . In reality, the vast majority of patients treated using tibial nerve receive treatment percutaneously (PTNS) by inserting a needle into their lower leg. PTNS requires 12 visits to a physician's office and a painful treatment experience. From a physician's perspective PTNS is resource intensive in terms of time, financial and staff commitments. As a result, PTNS is often not a feasible option from the point of view of health care delivery. Moreover, the treatment may not be an option for patients whose schedule or ability to travel is limited. These issues are exacerbated for those with disabilities requiring special transport arrangements and who have trouble committing to 12 expensive and long trips to receive treatment. Additionally, 8% of patients who undergo PTNS complain of adverse effects which include pain, bruising, tingling or bleeding at the insertion site of the 34-gauge needle. As a direct result of these limitations long-term follow up studies of patients undergoing PTNS treatment show poor compliance to PTNS over time . Non-invasive, homecare TTNS devices such as the ZIDA Wearable Neuromodulation System are on the cusp of achieving regulatory clearance. TTNS, stimulates transcutaneously at a home-based setting and at least one study has explored the efficacy of this treatment method . Early results have demonstrated improvements in OAB symptom scores and urodynamic parameters . So far, these studies have employed standard commercial TENS devices (transcutaneous electrical nerve stimulation). These studies have used a variety of treatment frequencies to stimulate the tibial nerve at frequencies between 10 to 40 Hz, patient have been advised which pre-determined stimulation settings can be used for home care treatment. Commercial TENS devices limit mobility of patients during the time that the nerve is being stimulated.

NCT ID: NCT04470440 Completed - Prognosis Clinical Trials

Thyroid Dysfunction and Nivolumab Reponse in NSCLC

THYRONIVO
Start date: October 22, 2019
Phase:
Study type: Observational

This is an observational, retrospective and monocentric study, conducted at the university Hospital of Brest The primary objective is to assess the association between the occurrence of thyroid dysfunction in patients treated with Nivolumab® for a non-small cell lung cancer and prognosis and therapeutic response The second objective is to assess prognosis and therapeutic response according to severity and subtype of thyroid dysfunction